DE69835766D1 - Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon - Google Patents

Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon

Info

Publication number
DE69835766D1
DE69835766D1 DE69835766T DE69835766T DE69835766D1 DE 69835766 D1 DE69835766 D1 DE 69835766D1 DE 69835766 T DE69835766 T DE 69835766T DE 69835766 T DE69835766 T DE 69835766T DE 69835766 D1 DE69835766 D1 DE 69835766D1
Authority
DE
Germany
Prior art keywords
apoep1
compositions
apolipoprotein
peptide
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69835766T
Other languages
English (en)
Other versions
DE69835766T2 (de
Inventor
Bhagirath Singh
Beverley Rider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Western Ontario
Original Assignee
University of Western Ontario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Western Ontario filed Critical University of Western Ontario
Application granted granted Critical
Publication of DE69835766D1 publication Critical patent/DE69835766D1/de
Publication of DE69835766T2 publication Critical patent/DE69835766T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69835766T 1997-12-12 1998-12-11 Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon Expired - Lifetime DE69835766T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6953197P 1997-12-12 1997-12-12
US69531P 1997-12-12
PCT/CA1998/001129 WO1999031227A2 (en) 1997-12-12 1998-12-11 NOVEL PEPTIDE, apoEp1.B, COMPOSITIONS AND USES THEREOF

Publications (2)

Publication Number Publication Date
DE69835766D1 true DE69835766D1 (de) 2006-10-12
DE69835766T2 DE69835766T2 (de) 2007-09-13

Family

ID=22089612

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835766T Expired - Lifetime DE69835766T2 (de) 1997-12-12 1998-12-11 Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon

Country Status (8)

Country Link
US (1) US6652860B1 (de)
EP (1) EP1036174B1 (de)
AT (1) ATE338118T1 (de)
AU (1) AU1552599A (de)
CA (1) CA2314397C (de)
DE (1) DE69835766T2 (de)
ES (1) ES2276481T3 (de)
WO (1) WO1999031227A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844315B2 (en) * 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
EP1138692A1 (de) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (de) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
US20030113808A1 (en) * 2001-12-13 2003-06-19 George Jackowski Apolipoprotein biopolymer markers predictive of alzheimers disease
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US20080194489A1 (en) * 2001-12-21 2008-08-14 Khan Nisar A Treatment of iatrogenic disease
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20090191105A1 (en) * 2004-08-30 2009-07-30 Kazuhiro Tanahashi Fractionation Apparatus
WO2006079622A2 (de) 2005-01-28 2006-08-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur herstellung von isochroman und derivaten davon
WO2007004869A2 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
WO2010002982A1 (en) * 2008-07-01 2010-01-07 Cognosci, Inc. Methods of treating cancer with apoe peptides
EP2408812B1 (de) 2009-03-17 2015-12-16 CardioVax, LLC Immunmodulatorische Verfahren und Systeme zur Behandlung und/oder Prävention von Atherosklerose sowie zugehörige Proteine, Peptide und Zusammensetzungen
EP2305277A1 (de) * 2009-09-18 2011-04-06 Forskarpatent I Syd AB Verwendung von tolerogenen dendritischen Zellen bei der Behandlung und Vorbeugung von Atherosklerose
JP2013510586A (ja) 2009-11-14 2013-03-28 チュウ、カン−ユウ アテローム性動脈硬化を治療及び／又は予防するための免疫調節方法及びシステム
US20130005645A1 (en) 2010-01-06 2013-01-03 Vitek Michael P Apoe peptide dimers and uses thereof
JP2013544243A (ja) 2010-11-12 2013-12-12 シーダース シナイ メディカル センター 動脈瘤の治療及び／又は予防のための免疫調節方法及びシステム
AU2011336997A1 (en) 2010-11-12 2013-05-30 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
CN116271053A (zh) 2012-08-13 2023-06-23 洛克菲勒大学 治疗和诊断黑素瘤
US11214536B2 (en) 2017-11-21 2022-01-04 Inspirna, Inc. Polymorphs and uses thereof
JP2023509845A (ja) 2019-12-13 2023-03-10 インスピルナ，インコーポレーテッド 金属塩及びその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587989B2 (en) 1984-10-16 1989-09-07 Mitsubishi Chemical Corporation DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins

Also Published As

Publication number Publication date
WO1999031227A2 (en) 1999-06-24
AU1552599A (en) 1999-07-05
ES2276481T3 (es) 2007-06-16
DE69835766T2 (de) 2007-09-13
EP1036174B1 (de) 2006-08-30
WO1999031227A3 (en) 1999-07-29
CA2314397C (en) 2010-04-13
CA2314397A1 (en) 1999-06-24
US6652860B1 (en) 2003-11-25
ATE338118T1 (de) 2006-09-15
EP1036174A2 (de) 2000-09-20

Similar Documents

Publication Publication Date Title
DE69835766D1 (de) Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon
WO1999012968A3 (en) Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
DE60144145D1 (de) Subtilisin-variante
ATE368053T1 (de) Antimikrobielle peptide
CA2270289A1 (en) Proteins with enhanced levels of essential amino acids
WO2003096984A3 (en) Drug therapy for celiac sprue
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
BR9708220A (pt) Peptìdios de ligação hla-a2.1 e seus usos
MX9700851A (es) Adenovirus que comprende un gen codificante para la glutation peroxidasa.
WO2001025438A3 (en) Ifn-alpha homologues
IT1212508B (it) Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
MY104909A (en) Peptide compounds.
IL126221A0 (en) Scf analog compositions and methods
WO1998017626A3 (en) Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
ATE352556T1 (de) Zytomodulierende lipophile peptide zur modulation der immunsystemaktivität und hemmung von entzündungen
DE60044038D1 (de) Xylosyltransferase und isoformen
ES8801316A1 (es) Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ATE371737T1 (de) Proteaseresistente flint-analoge
AR009840A1 (es) Preparado vacunal para la inmunocastracion revesible de mamiferos
ATE427355T1 (de) Menschliche alpha2-delta4-calciumkanal- untereinheit codierende cdna
DE60044468D1 (de) Herstellung von sekretierten polypeptiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition